314768-97-3

Basic information

• Product Name: 2-AMINO-5-PIPERIDIN-1-YLBENZAMIDE
• Synonyms: 2-AMINO-5-PIPERIDIN-1-YLBENZAMIDE
• CAS NO: 314768-97-3
• Molecular Formula: C₁₂H₁₇N₃O
• Molecular Weight: 219.28288
• Mol File: 314768-97-3.mol
• Article Data: 7

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2-AMINO-5-PIPERIDIN-1-YLBENZAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 2-AMINO-5-PIPERIDIN-1-YLBENZAMIDE(314768-97-3)
• EPA Substance Registry System: 2-AMINO-5-PIPERIDIN-1-YLBENZAMIDE(314768-97-3)

Safety Data

• Hazardous Substances Data: 314768-97-3(Hazardous Substances Data)

Usage

Chemical compound

2-AMINO-5-PIPERIDIN-1-YLBENZAMIDE

Upstream product

• 421558-77-2 2-nitro-5-(piperidin-1-yl)benzamide 
• 110-89-4 piperidine 
• 40763-96-0 2-nitro-5-chlorobenzamide 
• 2516-95-2 5-chloro-2-nitrobenzoic acid 
• 41994-44-9 5-chloro-2-nitrobenzoyl chloride 
• 455-38-9 3-fluorobenzoic acid 
• 320-98-9 5-fluoro-2-nitrobenzoic acid 
• 394-02-5 5-fluoro-2-nitrobenzoyl chloride 
• 77206-97-4 2-nitro-5-fluorobenzamide 

Downstream Products

• 314769-08-9 2-(3'-Methoxyphenyl)-6-(piperidinyl)-4-quinazolinone 

Relevant articles and documents

Synthesis and preliminary cytotoxic and antifungal evaluation of some 6-N,N-dialkyl 2-aryl-4(3H)-quinazolinone derivatives

Some new 2-aryl-4-quinazolinone derivatives bearing a cyclic amino group at position 6 were prepared and their preliminary cytotoxic and antifungal evaluation is reported. They all showed a moderate cytotoxicity suggesting that not only the oxidation stat

Molecular modelling, synthesis, cytotoxicity and anti-tumour mechanisms of 2-aryl-6-substituted quinazolinones as dual-targeted anti-cancer agents

Background and Purpose Our previous study demonstrated that 6-(pyrrolidin-1-yl)-2-(3-methoxyphenyl)quinazolin-4-one (HMJ38) was a potent anti-tubulin agent. Here, HMJ38 was used as a lead compound to develop more potent anti-cancer agents and to examine t

INDAZOLINONE COMPOSITIONS USEFUL AS KINASE INHIBITORS

The present invention provides compounds of formula (I): These compounds, and pharmaceutically acceptable compositions thereof, are useful generally as kinase inhibitors, particularly as inhibitors of PRAK, GSK3, ERK2, CDK2, MK2, SRC, SYK, and Aurora-2. Accordingly, compounds and compositions of the invention are useful for treating or lessening the severity of a variety of disorders, including, but not limited to, heart disease, diabetes, Alzheimer's disease, immunodeficiency disorders, inflammatory diseases, allergic diseases, autoimmune diseases, destructive bone disorders such as osteoporosis, proliferative disorders, infectious diseases and viral diseases.